Transcatheter Patent Ductus Arteriosus (PDA) Closure
Transcatheter Patent Ductus Arteriosus (PDA) Closure is organized by The Pediatrix Center for Research, Education, Quality and Safety (CREQS).
Release Date: 06/04/2021
Expiration Date for Credit: 06/03/2024
Overview
Conservative Patent Ductus Arteriosus (PDA) management have historically taken precedence within the clinical arena. This presentation will address the variability in management of Patent Ductus Arteriosus (PDA) in the premature neonate, as well as aim to help providers understand the pathogenesis of PDA and how the evolution of its management pathway contribute to a multi-disciplinary quality improvement of PDA closure in premature neonates.
ACCME Objectives
• Explain the anatomy, physiology, and pathophysiology of the patent ductus arteriosus (PDA).
• Summarize the history and evolution of PDA management strategies.
• Discuss ongoing efforts at Orlando Health to optimize PDA management for premature neonates.
ANCC Learning Outcomes
• Explain the anatomy, physiology, and pathophysiology of the patent ductus arteriosus (PDA).
• Summarize the history and evolution of PDA management strategies.
• Discuss ongoing efforts at Orlando Health to optimize PDA management for premature neonates.
